Login / Signup

Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study.

Marios C PantzarisChristos BakirtzisNikolaos GrigoriadisGeorgios HadjigeorgiouEfthimos DardiotisGeorge LoucaidesEvangelia NtzaniGeorgios MarkozannesSavvas OmorfosPaola ValsasinaRoberta MessinaPaolo PreziosaMaria Assunta RoccaIoannis Patrikios
Published in: BMJ neurology open (2022)
ISRCTN06166891.
Keyphrases
  • double blind
  • phase iii
  • multiple sclerosis
  • placebo controlled
  • clinical trial
  • open label
  • phase ii
  • study protocol
  • early stage
  • white matter
  • disease activity